Thymosin Beta-4 Dosage Calculator
Thymosin Beta-4 (Tb4) is the full-length 43-amino-acid protein and the primary G-actin sequestering peptide in the human body.
750mcg · Daily
Summary: Add 1mL BAC water to your 2mg vial. Draw to 37.5 units on a U-100 syringe for a 750mcg dose. This vial will last 2 doses.
Cycle Planner
Thymosin Beta-4 Pharmacokinetics
Pharmacokinetics — Active Dose Over Time
t½ = ~2 hours (IV)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Thymosin Beta-4 Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 750mcg | Daily |
| Moderate | 1,500mcg | Daily |
| Aggressive | 3mg | Daily |
Note: Full-length 43-amino-acid protein, distinct from TB-500 which is only the 7-amino-acid active fragment. Due to short half-life, daily dosing is standard. Loading phase of 2-4 weeks at higher dose, then reduce to maintenance. Store reconstituted vial refrigerated.
About Thymosin Beta-4
Thymosin Beta-4 (Tb4) is the full-length 43-amino-acid protein and the primary G-actin sequestering peptide in the human body. Unlike TB-500, which contains only the central actin-binding fragment (amino acids 17-23), full-length Tb4 retains additional functional domains including the Ac-SDKP sequence responsible for cardioprotective and anti-fibrotic effects. Tb4 promotes wound healing, angiogenesis, and tissue regeneration while reducing inflammation and scar formation. It is the first known molecule demonstrated to simultaneously initiate myocardial and vascular regeneration after systemic administration in preclinical models.